Since joining Vertex Pharmaceuticals in 2015, David Altshuler, MD, PhD, has been instrumental in bringing several new medicines to patients living with serious genetic diseases, most notably cystic fibrosis (CF), including ORKAMBI®, SYMDEKO® and TRIKAFTA . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge